Skip to Content

Notice

Meeting of the Drug Control Research, Data, and Evaluation Committee

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Office of National Drug Control Policy.

ACTION:

Notice of meeting.

SUMMARY:

ONDCP will convene a meeting of the Drug Control Research, Data, and Evaluation Advisory Committee on January 17-18, 2002, at the White House Conference Center located at 726 Jackson Place, NW., Washington, DC. The meeting will begin promptly each day at 9 am and adjourn at 4 pm. The agenda will include general discussion and briefs on national drug use indicators and other federal drug control initiatives including, but not limited to the following: (1) Interagency Oxycontin Work Group Progress Report on an Early Warning System for Pharmaceutical Diversion Abuse; (2) a Redesign Proposal for the Drug Abuse Warning Network (DAWN); (3) ONDCP's Anti-Drug Media Campaign Evaluation; (4) 2001 National Household Survey on Drug Abuse State Estimates of Treatment Need and Drug Use Prevalence; (5) The RAMONA Project (Random Access Monitoring of Narcotics Addicts); (6) HHS's Report on Closing the Drug Abuse Treatment Gap: A Report to the President of the U.S.; (7) Updates on Drug Free Communities Grant Program; and (8) Activities related to: prevention, families, schools, and workplaces. There will be an opportunity for public comment from 11:30 am to 12 Noon on Thursday, January 17, 2002.

DATES:

January 17-18, 2002, 9 am to 4:00 pm. Opportunity for public comment from 11:30 am to 12:00 noon on Thursday, January 17, 2002.

ADDRESSES:

White House Conference Center, 726 Jackson Place, NW, Washington, DC.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Linda V. Priebe, Assistant General Counsel, Office of National Drug Control Policy, Washington, DC (202) 395-6622.

Start Signature

Dated: December 11, 2001.

Linda V. Priebe,

Assistant General Counsel.

End Signature End Further Info End Preamble

[FR Doc. 01-31055 Filed 12-17-01; 8:45 am]

BILLING CODE 3180-02-P